Background {#Sec1}
==========

Acute kidney injury (AKI) is common during critical illness, affecting \> 50% of patients in the intensive care unit (ICU) \[[@CR1]\]. It is a syndrome rather than a defined diagnosis, has many different aetiologies and can develop at different stages throughout critical illness \[[@CR2]\]. There is increasing evidence that AKI is associated with short- and long-term complications and high healthcare costs \[[@CR3]\]. Patients who leave hospital alive remain at risk of chronic health problems, including chronic kidney disease (CKD) and end-stage renal disease (ESRD) \[[@CR4], [@CR5]\]. The risk is particularly high in patients with more severe, recurrent or prolonged AKI and in those with reduced renal functional reserve.

Many patients already suffer from AKI when admitted to the ICU but a large proportion develop AKI later whilst receiving critical care \[[@CR6]\]. Their risk of dying is significantly higher than that of patients with AKI on admission. There is a clear need for better strategies to prevent the development of AKI during critical illness and to reduce the risk of progression in those who develop AKI. Although some risk factors are not modifiable, for instance advanced age or pre-existing CKD, others are avoidable or potentially amenable to modification, for instance exposure to nephrotoxic drugs \[[@CR7]--[@CR9]\]. A better understanding of the risk of ICU-acquired AKI and the identification of potentially modifiable risk factors is essential to reduce the global burden of AKI.

The objectives of this study were (a) to identify factors associated with the development of new AKI during early stay in the ICU and (b) to ascertain risk factors for non-recovery of AKI.

Methods {#Sec2}
=======

Setting {#Sec3}
-------

Guy's and St Thomas' NHS Foundation Hospital is a tertiary care centre with a 54-bed consultant-led multi-disciplinary ICU. The ICU has a fully computerized electronic patient record system where all data are recorded at the time of generation.

Patients and study design {#Sec4}
-------------------------

We analysed the departmental database containing prospectively collected data of adult patients (≥ 18 years) admitted to the ICU between January 2014 and December 2016 and identified all patients with AKI as defined by the urine and creatinine criteria of the Kidney Disease Improving Global Outcome (KDIGO) classification \[[@CR9]\]. In cases where baseline renal function was not available, we retrospectively imputed the serum creatinine using the Modification of Diet in Renal Disease (MDRD) equation, as suggested by the KDIGO expert group \[[@CR9]\].

In our ICU, serum creatinine is measured on admission to the ICU, routinely every morning at around 6 a.m. and in-between as directed by the clinical team. Urine output is monitored and recorded hourly. To identify factors associated with the new development of AKI, we only analysed patients who did not have AKI in the first 24-h time period after ICU admission \[[@CR10]\]. Therefore, we excluded patients with (i) AKI on admission or within the first 24 h of admission to the ICU, (ii) known ESRD, (iii) a renal transplant, (iv) renal replacement therapy (RRT) prior to ICU admission and (v) admission to the ICU after a nephrectomy. Other exclusion criteria were previous admission to the ICU during the same hospitalization, ICU stay \< 48 h and pregnancy. We compared patients who developed AKI between the 24--72-h time period after admission to the ICU with patients who did not develop AKI within 7 days after admission to the ICU.

Among patients with AKI acquired in the ICU, we determined the degree of renal recovery at day 7 after ICU admission and distinguished between (a) full renal recovery (i.e. return of serum creatinine to baseline and urine output \> 0.5 ml/kg), (b) partial renal recovery (i.e. improvement of AKI to lower stage but no return to baseline) and (c) no renal recovery. Patients who were receiving RRT on day 7 were classified as having "no renal recovery"; patients who had received RRT in the first 6 days in the ICU and were no longer on RRT on day 7 were classified as having "partial recovery" independent of serum creatinine concentration. We also collected serum creatinine results at hospital discharge and investigated a change from baseline.

Data collection {#Sec5}
---------------

We extracted the following data: demographics, chronic co-morbidities, Sequential Organ Failure Assessment (SOFA) score on admission to the ICU and on the first day of AKI, daily haemodynamic variables and serum creatinine for 7 days after admission to the ICU and at hospital discharge. Daily cumulative fluid balance was calculated automatically in our electronic medical records and defined as the difference between the total fluid intake from all sources (intravenous fluids, blood products, enteral and parenteral nutrition and medications) and total output (urine, effluent, output from drains and gastrointestinal losses). We recorded daily cumulative fluid balance in millilitres/24 h and percentage body weight (BW %). We extracted data on the type of organ support, use of diuretics and exposure to specific nephrotoxic medications (aminoglycosides, non-steroidal anti-inflammatory drugs, including paracetamol, chemotherapy, contrast, vancomycin and antiretroviral drugs).

In the cohort of patients who developed new AKI during the 24--72-h period in the ICU, we identified the median day of AKI development and used this day as the reference point for comparison with the non-AKI group. To identify risk factors for non-recovery of renal function, we distinguished between factors prior to the development of new AKI and factors post-onset of AKI. The main outcomes were the development of new AKI, renal function on day 7 or day of hospital discharge (whatever occurred first) and survival status at the ICU and hospital discharge.

Statistical analysis {#Sec6}
--------------------

Continuous variables were summarized as mean and standard deviation (SD) or median and interquartile range (IQR) and compared between those who did and did not develop AKI in the first 24--72 h in the ICU, and those who did and did not recover from AKI, using the independent-samples *t* test or Mann-Whitney *U* test, as appropriate. Categorical variables were summarized as frequencies and percentages and compared using the chi-squared test. In the first multivariable model, the relationships between odds of developing AKI and demographic and clinical characteristics significant in univariable analyses were explored using logistic regression. Variables with small sample sizes (e.g. epinephrine use) and variables that were highly colinear with other variables (e.g. CKD and baseline serum creatinine) were not included in the multivariable analyses. Fractional polynomials were used to model the non-linear relationship between fluid balance and risk of AKI. In patients with AKI, multivariable logistic regression models were also used to explore the relationship between odds of non-recovery and (a) variables known on the first day of AKI only and (b) variables representing conditions after the development of AKI only. Fractional polynomials were again used to explore the effect of cumulative fluid balance in model (1) and net fluid balance on day of AKI (2). Survival analysis was used to describe cumulative hospital survival. *p* values \< 0.05 were considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics 20.0 and STATA 15/IC.

Results {#Sec7}
=======

Between January 2014 and December 2016, 5990 patients were admitted to the ICU; 2525 patients did not have AKI on admission and did not meet any exclusion criteria (Fig. [1](#Fig1){ref-type="fig"}). Among this cohort, 840 (33%) patients developed new AKI at median day 3 (IQR 2--4) compared to 1685 (67%) patients who did not develop AKI during the first 7 days in the ICU. The majority of patients with new AKI had AKI stage I (41%) followed by AKI stage II (35%) and AKI stage III (24%). Patients who developed new AKI were older and characterized by a significantly higher SOFA score and higher CVP on admission to the ICU, a higher prevalence of pre-existing CKD and cardiovascular disease, greater need for advanced organ support, higher cumulative fluid balance and longer periods of inotrope and/or vasopressor support compared to patients without new AKI. (Table [1](#Tab1){ref-type="table"}). Fig. 1Patient flow. AKI acute kidney injury, ICU intensive care unit, RRT renal replacement therapy Table 1Demographic and baseline clinical parametersVariables\*All patients without AKI on admission (*n* = 2525)New AKI in the ICU (*n* = 840)No new AKI in the ICU (*n* = 1685)*p* valueDemographics Age62 \[48, 74\]64 \[51, 74\]61 \[43, 72\]0.02 Male sex1498 (59.3)519 (62.0)979 (58.0)0.06 BMI24.2 \[23, 28.1\]25.4 \[23.5, 30.0\]24.2 \[22.9, 29.0\]\<0.001 Body weight \[kg\]70 \[63, 81\]73 \[65, 89\]70 \[60, 78\]\< 0.001Parameters on the day of ICU admission Medical admission2012 (80)677 (81)1335 (79)0.69 Elective surgical admission367 (15)113 (14)254 (16) Emergency surgical admission146 (5)50 (6)96 (6) Lowest MAP \[mmHg\]59 \[53, 64\]56 \[51, 61\]59 \[55, 62\]0.01 SOFA score5 \[3, 7\]5 \[3, 8\]4 \[3, 7\]\<0.001 CVP \[mmHg\]12 \[8, 17\]13 \[9, 18\]11 \[7, 16\]\<0.001Comorbidities Baseline serum creatinine \[μmol/L)83 \[63, 113\]100 \[75, 140\]81 \[60, 117\]\<0.001 Chronic kidney disease228 (9.0)111 (13.3)117 (6.9)\<0.001 Chronic lung disease715 (28.3)246 (29.4)469 (27.8)0.40 Chronic liver disease1645 (65.1)553 (66.1)1092 (67.1)0.51 Cardiovascular disease545 (21.6)222 (26.5)343 (20.3)\<0.001 Congestive heart failure200 (8.0)80 (9.6)120 (7.1)0.04 Diabetes mellitus517 (20.5)197 (23.5)320 (19.0)0.01 Cerebrovascular disease206 (8.2)73 (8.7)133 (7.9)0.49 Cancer730 (28.9)218 (26.0)512 (30.3)0.03Primary diagnostic code for ICU admission Respiratory899 (35.6)298 (35.6)601 (35.6)1.00 Neurologic179 (7.1)61 (7.3)118 (7.0)0.81 Post-surgery429 (17.0)132 (15.8)297 (17.6)0.26 Cardiovascular391 (15.4)145 (17.3)246 (14.6)0.08 Gastrointestinal183 (7.2)59 (7.0)124 (7.3)0.81 Urinary57 (2.3)14 (1.7)43 (2.5)0.20 Sepsis210 (8.3)84 (10.0)126 (7.5)0.03 Other339 (13.4)109 (13.0)230 (13.6)0.71Organ support from ICU admission to the day of AKI or day 3 Mechanical ventilation1444 (57.2)512 (61.2)932 (55.2)0.04 ECMO130 (5.1)61 (7.3)69 (4.1)0.01 IABP62 (2.5)31 (3.7)31 (1.8)0.01 Surgery101 (4.0)35 (4.2)66 (3.9)0.75 Epinephrine27 (1.1)13 (1.6)14 (0.8)0.10 Norepinephrine1050 (41.6)427 (50.8)627 (37.1)\<0.001 Vasopressin9 (0.4)5 (0.6)4 (0.2)0.17Time (in the first 7 days) spent on inotropic and vasoactive medications Number of days on at least 1 inotrope or vasopressor0 \[0, 0\]1 \[0, 3\]0 \[0, 2\]\< 0.001 0 days1405 (56)382 (45)1023 (61) 1--3 days725 (29)252 (30)473 (28) 4 or more days395 (16)206 (25)189 (11) Number of days on \> 1 inotrope or vasopressor0 \[0, 0\]0 \[0, 0\]0 \[0, 0\]\< 0.001 0 days2324 (92)737 (88)1587 (94) 1--3 days178 (7)87 (10)91 (5) 4 or more days23 (1)16 (2)7 (0) Number of days on at least 1 vasopressor0 \[0, 0\]1 \[0, 3\]0 \[0, 2\]\< 0.001 0 days1428 (57)386 (46)1042 (62) 1--3 days718 (28)251 (30)467 (28) 4 or more days379 (15)203 (24)176 (11) Number of days on \> 1 vasopressor0 \[0, 0\]0 \[0, 0\]0 \[0, 0\]0.001 0 days2502 (99)825 (98)1677 (99) 1--3 days23 (1)15 (2)8 (1) 4 or more days000Potentially nephrotoxic exposures Vancomycin240 (9.5)82 (9.8)158 (9.4)0.72 Diuretic1185 (46.9)381 (45.5)804 (47.6)0.33 Aminoglycosides899 (35.6)291 (34.8)608 (36.0)0.57 ACE-I/ARB180 (7.1)67 (8.0)113 (6.7)0.25 Contrast252 (10.0)88 (10.5)164 (9.7)0.53 Chemotherapy42 (1.7)11 (1.3)31 (1.8)0.88 Antiretroviral drugs40 (1.6)11 (1.3)30 (1.8)0.41 NSAID51 (2.0)8 (1.0)43 (2.5)0.01Fluid balance on the day of AKI/day 3 Cumulative FB in ml1389 (3455)2148.4 (3667.5)1002 (3276)\<0.001 % of fluid balance in % BW1.66 \[−0.7, 4.3\]3.98 \[1.2, 6.9\]2.29 \[−0.07, 5.14\]\<0.001Outcomes ICU stay (days)13 \[9, 21\]9 \[5, 17\]\< 0.01 Hospital stay (days)31 \[19, 56\]22 \[12, 43\]0.94 ICU mortality (%)175 (20.9)94 (5.6)\< 0.01 Hospital mortality (%)273 (35.4)243 (15.4)\< 0.01*ACE-I* angiotensin converting enzyme inhibitor, *ARB* angiotensin receptor blocker, *AKI* acute kidney injury, *BMI* body mass index, *BW* body weight, *CVP* central venous pressure, *ECMO* extracorporeal membrane oxygenation, *FB* fluid balance, *IABP* intra-aortic balloon pump, *ICU* intensive care unit, *MAP* mean arterial pressure, *NSAID* non-steroidal anti-inflammatory drug, *SD* standard deviation, *SOFA* Sequential Organ Failure Assessment\*Results displayed as *n* (%), mean (SD) or median \[interquartile range\]

Among all patients with new AKI, 550 patients developed AKI during the 24- to 72-h period after admission to the ICU. Their ICU mortality was 19.8% and hospital mortality was 32.2%. Among this cohort, 379 (69%) had full recovery of renal function during the 7-day period after admission to the ICU, 45 (8%) had partial renal recovery, and in 126 (23%) patients, renal function did not improve (Fig. [1](#Fig1){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}). Patients without renal recovery were characterized by a higher SOFA score and higher CVP prior to the development of AKI and in the following 24--48 h (Additional file [1](#MOESM1){ref-type="media"} and Additional file [2](#MOESM2){ref-type="media"}). In addition, a higher proportion of AKI patients with non-recovery were treated with extracorporeal membrane oxygenation (ECMO), mechanical ventilation and/or noradrenaline following the development of AKI suggesting that they had more associated organ failure. The risk of non-recovery was higher in patients with AKI stage III (Additional file [2](#MOESM2){ref-type="media"}). Finally, among 177 patients with new AKI who died in the hospital, 71 (40%) had no recovery of renal function compared to 56 of 373 patients (15%) with new AKI who were discharged from the hospital alive.

Multivariable analyses {#Sec8}
----------------------

Multivariable logistic regression analysis showed that BMI, SOFA score on admission to the ICU, pre-existing CKD and cumulative FB on day of AKI or day 3 were independently associated with new AKI (Table [2](#Tab2){ref-type="table"}). In a separate model including cumulative fluid balance in the first 24 h, fluid balance was not associated with risk of developing AKI (OR = 0.98, 95% CI, 0.96--1.01, *p* = 0.159). Table 2Multivariate analysis of risk factors for the development of new acute kidney injuryVariablesOR95% CI for OR*p* valueLowerUpperAge1.001.001.010.24BMI1.061.041.07\<0.001SOFA score on admission to the ICU1.041.001.080.05Lowest MAP1.000.991.010.84Sepsis1.110.801.530.53Chronic kidney disease1.811.342.45\<0.001Atherosclerotic cardiovascular disease1.130.901.400.29Congestive heart failure1.120.811.560.50Diabetes mellitus1.060.851.330.60Cancer0.840.691.030.10Mechanical ventilation0.940.771.170.60Norepinephrine use1.200.941.540.15NSAID use0.480.221.050.07Cumulative fluid balance on the day of AKI or day 3 in the ICU1.111.081.14\<0.001Model diagnostics:There was no evidence of lack of fit (Hosmer Lemeshow *p* = 0.209) that the model was incorrectly specified (link test *p* = 0.300) or of multicollinearity among the included covariates (all variance inflation factors (VIF) \< 1.5). There was no evidence of a non-linear relationship between cumulative fluid balance and AKI*BMI* body mass index, *CI* confidence interval, *MAP* mean arterial pressure, *NSAID* non-steroidal anti-inflammatory drug, *SOFA* Sequential Organ Failure Assessment, *OR* odd ratio

In patients with new AKI, risk factors for non-recovery within the first 7 days included factors before and after the onset of new AKI. Independent pre-AKI risk factors for non-recovery were CKD, need for mechanical ventilation, use of diuretics and net FB on the first day of AKI (Table [3](#Tab3){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}a). Severity of AKI, mechanical ventilation and cumulative FB in the 48-h period after the day of AKI were independent post-AKI risk factors for non-recovery of renal function (Table [3](#Tab3){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}b). Table 3Multivariate analysis for risk of non-recovery after acute kidney injuryVariablesMVR (variables pre-AKI)^1^MVR (variables post-onset of AKI)^2^OR95% CI for OR*p* valueOR95% CI for OR*p* valueLowerUpperLowerUpperAKI stage1\< *0.001*AKI stage 20.630.311.280.21AKI stage 32.241.164.31*0.02*SOFA score on admission to the ICU1.050.961.150.26SOFA score on the day of AKI/day 3--------1.100.991.220.09Lowest MAP on the day of AKI--------0.990.961.020.36Chronic kidney disease2.011.123.58*0.02*2.821.375.78*0.01*Reason for admission: respiratory1.520.942.450.09Mechanical ventilation2.291.244.26*0.01*4.342.059.15\< *0.001*Norepinephrine use1.210.642.300.560.560.251.260.16Vancomycin use1.100.482.480.831.400.653.010.39Diuretic use1.891.202.97*0.01*Aminoglycoside use1.130.691.830.63Model diagnostics:There was no evidence of lack of fit (Hosmer Lemeshow *p* = 0.217 and 0.248) that the model was incorrectly specified (link test *p* = 0.082 and 0.345) or of multicollinearity among the included covariates (all variance inflation factors \< 3) for model MVR 1 or MVR 2*AKI* acute kidney injury, *CI* confidence interval, *MAP* mean arterial pressure, *ICU* intensive care unit, *MVR* multivariate analysis, *NSAID* non-steroidal anti-inflammatory drug, *SOFA* Sequential Organ Failure Assessment, *OR* odd ratio^1^Also adjusted for the non-linear association between fluid balance and non-recovery (*p* \< 0.001)^2^Also adjusted for the non-linear association between net fluid balance and non-recovery (*p* = 0.016) Fig. 2Association between fluid balance and non-recovery of renal function. **a** Association between net fluid balance on the first day of AKI and probability of renal non-recovery. **b** Association between cumulative fluid balance at 48 h after the onset of AKI and probability of renal non-recovery

Both net FB and cumulative FB showed an independent U-shape association with renal recovery (Fig. [2](#Fig2){ref-type="fig"}a and b). In sensitivity analyses in which models were fitted separately to those who died in the hospital and those discharged alive, the U-shape relationship was present in both groups (Additional file [5](#MOESM5){ref-type="media"}: Figure S1 and Additional file [6](#MOESM6){ref-type="media"}: Figure S2). There were 37 patients with a cumulative FB of − 5 l or more on the day of AKI or day 3 in the ICU (in patients without AKI); they were less likely to be male, more likely to have congestive heart failure, chronic lung disease, a respiratory diagnosis, to be on ECMO and to have received a diuretic than those with cumulative FB less than − 5 l (Additional file [3](#MOESM3){ref-type="media"}). There were also 271 patients with a cumulative FB greater than + 5 l which was associated with lower MAP, higher baseline serum creatinine, known cardiovascular disease, gastrointestinal and sepsis diagnoses on admission and the use of norepinephrine.

Outcomes {#Sec9}
--------

Hospital mortality was significantly higher in patients who developed AKI in the ICU compared to those without AKI (35.4% versus 15.4%, *p* = 0.01) (Table [1](#Tab1){ref-type="table"}). Among AKI patients, hospital mortality was lowest in those who had full renal recovery in the first 7 days (22.8%) compared to patients with partial renal recovery (59.5%) or no recovery (64%) (Additional file [4](#MOESM4){ref-type="media"} and Additional file [7](#MOESM7){ref-type="media"}: Figure S3). AKI patients also had a longer length of stay in the ICU, especially if renal function did not recover.

Discussion {#Sec10}
==========

This retrospective analysis demonstrates that ICU-acquired AKI is common and associated with a high risk of death, especially if renal function does not recover quickly. More than 30% of critically ill patients who did not have AKI on admission to the ICU developed AKI during the first 24 to 72 h in the ICU. Pre-existing CKD, more severe AKI, need for mechanical ventilation and diuretic use were independently associated with a higher risk of non-recovery. Cumulative fluid balance was strongly associated with both the development of AKI and non-recovery. For non-recovery of renal function, the association was U-shaped; both extremely negative and extremely positive cumulative fluid balance were harmful to the kidney function. Finally, the chances of being discharged alive from the hospital were significantly better in patients who either did not develop AKI or recovered renal function within 1 week compared to those who still had AKI on day 7.

Although it is not always possible to modify risk factors for AKI, many episodes of AKI are considered to be preventable. It is therefore essential to identify those risk factors that can either be avoided or altered. In our analysis, cumulative fluid balance emerged as a strong risk factor with a U-shape association. Both inadequate fluid administration and fluid accumulation were independently associated with an increased risk of non-recovery. Cumulative fluid balance by the day of AKI (or day 3 in the ICU) was also strongly associated with the development of new AKI. Raimundo et al. previously showed that increased fluid administration in early AKI was an independent risk factor for progression to AKI stage III \[[@CR11]\]. Data from the Sepsis Occurrence in Acutely Ill Patients demonstrated a 54% adjusted risk of death at 60 days in patients with AKI and a mean positive fluid balance \[[@CR12]\]. Although the exact reasons for the deleterious impact of fluid overload on renal function are not known, obstruction of capillary blood flow and lymphatic drainage, renal congestion and impaired tissue oxygenation are likely to play an important role \[[@CR13], [@CR14]\]. These effects are particularly pronounced in encapsulated organs such as the liver and kidneys that lack the capacity to accommodate extra volume without an increase in the interstitial pressure. Importantly, there is no evidence that fluid accumulation is beneficial or necessary in AKI or during acute illness. Van Biesen et al. previously showed that additional fluid loading not only failed to improve renal function but was also associated with worsening respiratory function \[[@CR15]\].

Fluid management is a key component of prevention and management of AKI \[[@CR9], [@CR16]\]. Although we showed that both negative and positive fluid balance were associated with worse outcomes, it is important to note that our study and others in the literature only demonstrate associations but do not prove a causal relationship \[[@CR11], [@CR12], [@CR17]\]. It is certainly possible that there was more haemodynamic instability and hypotension among those who received larger volumes of fluid and accumulated more fluid and that haemodynamic instability per se may have contributed to the risk of AKI. The role of active fluid restriction in AKI with focus on the prevention of fluid overload has not been studied prospectively. However, data from the CLASSIC feasibility study showed that a protocol of restricting fluid administration after initial resuscitation in patients with septic shock was safe and associated with less worsening of AKI compared to standard care \[[@CR18]\]. Until more data are available, our results, together with reports in the literature suggest that regular assessment of both daily fluid balance and cumulative fluid balance are crucial. Whilst fluid administration is an important component of the initial resuscitation phase and serves to prevent AKI in patients with intravascular hypovolaemia, there comes a point when fluids have a deleterious effect on renal function. Unfortunately, the exact timing and how best to identify the time point remain unclear.

Another interesting result of our analysis was the emergence of obesity as an independent risk factor for the development of AKI. Previous studies showed a higher risk of AKI in trauma and acute lung injury patients with higher BMI \[[@CR19]--[@CR21]\]. Others pointed out that the association between BMI and risk of AKI appeared to be a "U"-shaped curve with both under- and overweight patients being particularly at risk \[[@CR22]\]. Billings et al. speculated that the association between obesity and AKI after cardiac surgery might be mediated by oxidative stress \[[@CR23]\]. It is also possible that inappropriate dosing of nephrotoxic drugs in patients with a higher BMI plays a role. However, it is also important to acknowledge that the utilization of weight-based urine volume criteria may overestimate the risk of AKI in patients with a higher BMI resulting in an overestimation of AKI \[[@CR24]\].

To the best of our knowledge, this study is the first to describe the non-linear relationship of cumulative FB and non-recovery of renal function. Both extremely negative and extremely positive FB were independently associated with non-recovery whilst increased FB was associated with the development of new AKI. These results should serve to underpin a future intervention trial exploring the role of fluid restriction in AKI.

Our analysis has some limitations which we would like to acknowledge. Due to the retrospective nature of the analysis, we were limited to the data that had been collected for clinical reasons. For instance, CVP measurements were not performed in all patients who developed AKI. As a result, we were not able to explore the relationship between CVP and AKI. Secondly, we defined ICU-acquired AKI as AKI that had developed at least 24 h after ICU admission. The decision was based on similar approaches in the literature \[[@CR10]\]. However, we acknowledge that serum creatinine and urine output are relatively late indicators of AKI and that in a proportion of patients categorized with "AKI after ICU admission", the onset of AKI may have been before ICU admission. In the future, the implementation of new AKI biomarkers may help to identify the onset of AKI more accurately and the AKI consensus definition and staging classification may be revised accordingly. Third, we excluded patients who developed AKI during the 72-h to 7-day period and acknowledge that they potentially had ICU-acquired AKI. The reason for excluding them was that we intended to analyse chances of renal recovery at day 7 and, therefore, we needed to allow patients with AKI a minimum time for kidney function to recover. Fourth, we evaluated renal recovery on day 7. The main reason was that we did not have complete data beyond this time period. We acknowledge that a proportion of patients may have either developed AKI later or recovered AKI after day 7. Fifth, in our models assessing factors associated with the development of new AKI, we included cumulative FB on the day of AKI (or day 3 in the ICU for those without AKI) and it is possible that the increased cumulative FB in those with AKI may be a consequence of AKI itself rather than a risk factor for AKI. Sixth, we used creatinine results without correcting for fluid balance. We acknowledge that AKI definition and classification could change with adjustment for fluid balance \[[@CR25]\]. However, the current AKI consensus definition is based on creatinine values without correction. Finally, our data stem from a large multi-disciplinary ICU in a single centre. Therefore, our conclusions may not be generalizable to other patient populations.

Conclusions {#Sec11}
===========

ICU-acquired AKI is associated with a high risk of mortality, especially if renal function does not recover by day 7. Cumulative fluid balance is a strong independent risk factor for the development and non-recovery of AKI with a U-shape relationship.
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